Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.06
WOOF's Cash-to-Debt is ranked lower than
81% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 0.40 vs. WOOF: 0.06 )
Ranked among companies with meaningful Cash-to-Debt only.
WOOF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.02  Med: 0.2 Max: No Debt
Current: 0.06
Equity-to-Asset 0.44
WOOF's Equity-to-Asset is ranked lower than
55% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 0.47 vs. WOOF: 0.44 )
Ranked among companies with meaningful Equity-to-Asset only.
WOOF' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.17  Med: 0.48 Max: 0.65
Current: 0.44
-0.17
0.65
Interest Coverage 11.26
WOOF's Interest Coverage is ranked higher than
59% of the 216 Companies
in the Global Medical Care industry.

( Industry Median: 8.17 vs. WOOF: 11.26 )
Ranked among companies with meaningful Interest Coverage only.
WOOF' s Interest Coverage Range Over the Past 10 Years
Min: 5.46  Med: 11.47 Max: 15.55
Current: 11.26
5.46
15.55
Piotroski F-Score: 5
Altman Z-Score: 4.08
Beneish M-Score: -3.93
WACC vs ROIC
8.69%
10.22%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 15.35
WOOF's Operating Margin % is ranked higher than
76% of the 255 Companies
in the Global Medical Care industry.

( Industry Median: 7.71 vs. WOOF: 15.35 )
Ranked among companies with meaningful Operating Margin % only.
WOOF' s Operating Margin % Range Over the Past 10 Years
Min: 5.47  Med: 15.18 Max: 20.17
Current: 15.35
5.47
20.17
Net Margin % 8.31
WOOF's Net Margin % is ranked higher than
68% of the 256 Companies
in the Global Medical Care industry.

( Industry Median: 4.84 vs. WOOF: 8.31 )
Ranked among companies with meaningful Net Margin % only.
WOOF' s Net Margin % Range Over the Past 10 Years
Min: 2.68  Med: 8.15 Max: 10.47
Current: 8.31
2.68
10.47
ROE % 15.30
WOOF's ROE % is ranked higher than
71% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 9.89 vs. WOOF: 15.30 )
Ranked among companies with meaningful ROE % only.
WOOF' s ROE % Range Over the Past 10 Years
Min: 3.98  Med: 13.59 Max: 24.23
Current: 15.3
3.98
24.23
ROA % 7.01
WOOF's ROA % is ranked higher than
67% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 4.66 vs. WOOF: 7.01 )
Ranked among companies with meaningful ROA % only.
WOOF' s ROA % Range Over the Past 10 Years
Min: 2.23  Med: 6.81 Max: 10.72
Current: 7.01
2.23
10.72
ROC (Joel Greenblatt) % 69.00
WOOF's ROC (Joel Greenblatt) % is ranked higher than
82% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 21.13 vs. WOOF: 69.00 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
WOOF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 23.39  Med: 64.63 Max: 116.35
Current: 69
23.39
116.35
3-Year Revenue Growth Rate 15.30
WOOF's 3-Year Revenue Growth Rate is ranked higher than
72% of the 183 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. WOOF: 15.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
WOOF' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 0  Med: 5.6 Max: 134.1
Current: 15.3
0
134.1
3-Year EBITDA Growth Rate 18.00
WOOF's 3-Year EBITDA Growth Rate is ranked higher than
73% of the 161 Companies
in the Global Medical Care industry.

( Industry Median: 8.10 vs. WOOF: 18.00 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
WOOF' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: -1.4 Max: 225.3
Current: 18
0
225.3
3-Year EPS without NRI Growth Rate 18.70
WOOF's 3-Year EPS without NRI Growth Rate is ranked higher than
69% of the 139 Companies
in the Global Medical Care industry.

( Industry Median: 8.40 vs. WOOF: 18.70 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
WOOF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -11.1 Max: 100
Current: 18.7
0
100
GuruFocus has detected 3 Warning Signs with VCA Inc $WOOF.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» WOOF's 10-Y Financials

Financials (Next Earnings Date: 2017-04-27)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

WOOF Guru Trades in Q1 2016

Paul Tudor Jones 8,200 sh (New)
Pioneer Investments 106,433 sh (+30.13%)
Third Avenue Management 132,590 sh (unchged)
Steven Cohen Sold Out
Larry Robbins 4,876,303 sh (-22.85%)
Jim Simons 960,800 sh (-23.25%)
Joel Greenblatt 4,580 sh (-77.29%)
» More
Q2 2016

WOOF Guru Trades in Q2 2016

Columbia Wanger 200,784 sh (New)
Steven Cohen 13,400 sh (New)
Pioneer Investments 106,433 sh (unchged)
Paul Tudor Jones Sold Out
Joel Greenblatt Sold Out
Jim Simons 853,400 sh (-11.18%)
Third Avenue Management 93,539 sh (-29.45%)
Larry Robbins 1,421,323 sh (-70.85%)
» More
Q3 2016

WOOF Guru Trades in Q3 2016

Ken Fisher 2,921 sh (New)
Paul Tudor Jones 3,900 sh (New)
Steven Cohen 78,700 sh (+487.31%)
Pioneer Investments 111,151 sh (+4.43%)
Larry Robbins Sold Out
Columbia Wanger 195,940 sh (-2.41%)
Third Avenue Management 80,794 sh (-13.63%)
Jim Simons 615,000 sh (-27.94%)
» More
Q4 2016

WOOF Guru Trades in Q4 2016

Andreas Halvorsen 545,862 sh (New)
Robert Olstein 122,150 sh (New)
Mario Gabelli 9,000 sh (New)
Columbia Wanger 893,802 sh (+356.16%)
Steven Cohen 307,200 sh (+290.34%)
Ken Fisher 2,921 sh (unchged)
Paul Tudor Jones Sold Out
Third Avenue Management 80,458 sh (-0.42%)
Pioneer Investments 71,538 sh (-35.64%)
Jim Simons 101,400 sh (-83.51%)
» More
» Details

Insider Trades

Latest Guru Trades with WOOF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 541940    SIC: 742
Compare:OTCPK:MCFFY, NYSE:EVHC, OTCPK:SKHCF, NYSE:MD, OTCPK:BDUUF, OTCPK:CAKFY, OTCPK:RMSYF, NAS:ACHC, NYSE:HLS, OTCPK:LTGHY, OTCPK:NWKHY, OTCPK:HHCSY, NYSE:CHE, NYSE:UHS, NAS:LPNT, NAS:SCAI, NYSE:AMN, NYSE:THC, NYSE:SEM, NAS:AMED » details
Traded in other countries:VCA.Germany,
Headquarter Location:USA
VCA Inc provides veterinary services and diagnostic testing to support veterinary care and sells diagnostic imaging equipment and other medical technology products and related services to the veterinary market.

Founded in 1986, VCA is the largest operator of freestanding, full-service animal hospitals and veterinary diagnostic labs in the United States. With over 750 pet hospitals, 60 reference labs, and 3,000 vets, the firm handled 9.8 million patient visits in 2015. It traded publicly from 1991 to 2000. After the company ran up a huge debt load to fund a buying binge in the late 1990s, a private investment group purchased and recapitalized the firm. VCA went public again in 2001.

Top Ranked Articles about VCA Inc

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against VCA Inc.

WILMINGTON, Del., March 07, 2017 (GLOBE NEWSWIRE) -- Rigrodsky & Long, P.A.:
Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the Central District of California on behalf of holders of VCA Inc. (“VCA”) (NASDAQ:WOOF) common stock in connection with the proposed acquisition of VCA by MMI Holdings, Inc., Venice Merger Sub Inc., and Mars, Incorporated (collectively, “Mars”) announced on January 9, 2017 (the “Complaint”).  The Complaint, which alleges violations of the Securities Exchange Act of 1934 against VCA, its Board of Directors (the “Board”), and Mars, is captioned Hight v. VCA Inc., Case No. 17-cv-00289 (C.D. Cal.). If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s counsel, Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242; by e-mail at [email protected]; or at: http://rigrodskylong.com/investigations/vca-inc-woof/. On January 7, 2017, VCA entered into an agreement and plan of merger (the “Merger Agreement”) with Mars.  Pursuant to the Merger Agreement, VCA shareholders will receive $93.00 per share in cash in a transaction valued at approximately $9.1 billion (the “Proposed Transaction”). Among other things, the Complaint alleges that, in an attempt to secure shareholder support for the Proposed Transaction, defendants issued materially incomplete disclosures in a proxy statement (the “Proxy Statement”) filed with the United States Securities and Exchange Commission on February 3, 2017.  The Proxy Statement, which recommends that VCA stockholders vote in favor of the Proposed Transaction, omits material information necessary to enable shareholders to make an informed decision as to how to vote on the Proposed Transaction, including material information with respect to VCA’s financial projections and the opinions and analyses of VCA’s financial advisor.  The Complaint seeks injunctive and equitable relief and damages on behalf of holders of VCA common stock.  If you wish to serve as lead plaintiff, you must move the Court no later than May 8, 2017.  A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.  Any member of the proposed class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities fraud, shareholder corporate, and shareholder derivative litigation on behalf of shareholders in state and federal courts throughout the United States. Attorney advertising.  Prior results do not guarantee a similar outcome.
CONTACT:

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242
(302) 295-5310
Fax: (302) 654-7530
[email protected]
http://www.rigrodskylong.com

Read more...

Ratios

vs
industry
vs
history
PE Ratio 35.79
WOOF's PE Ratio is ranked lower than
64% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. WOOF: 35.79 )
Ranked among companies with meaningful PE Ratio only.
WOOF' s PE Ratio Range Over the Past 10 Years
Min: 10.31  Med: 21.7 Max: 56.8
Current: 35.79
10.31
56.8
Forward PE Ratio 27.62
WOOF's Forward PE Ratio is ranked lower than
88% of the 108 Companies
in the Global Medical Care industry.

( Industry Median: 18.73 vs. WOOF: 27.62 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 35.79
WOOF's PE Ratio without NRI is ranked lower than
64% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 28.00 vs. WOOF: 35.79 )
Ranked among companies with meaningful PE Ratio without NRI only.
WOOF' s PE Ratio without NRI Range Over the Past 10 Years
Min: 10.31  Med: 21.7 Max: 56.8
Current: 35.79
10.31
56.8
Price-to-Owner-Earnings 28.22
WOOF's Price-to-Owner-Earnings is ranked lower than
52% of the 96 Companies
in the Global Medical Care industry.

( Industry Median: 27.48 vs. WOOF: 28.22 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
WOOF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.71  Med: 20.88 Max: 67.8
Current: 28.22
9.71
67.8
PB Ratio 5.05
WOOF's PB Ratio is ranked lower than
78% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 2.65 vs. WOOF: 5.05 )
Ranked among companies with meaningful PB Ratio only.
WOOF' s PB Ratio Range Over the Past 10 Years
Min: 1.23  Med: 2.66 Max: 7.79
Current: 5.05
1.23
7.79
PS Ratio 2.97
WOOF's PS Ratio is ranked lower than
71% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.57 vs. WOOF: 2.97 )
Ranked among companies with meaningful PS Ratio only.
WOOF' s PS Ratio Range Over the Past 10 Years
Min: 0.94  Med: 1.74 Max: 3.42
Current: 2.97
0.94
3.42
Price-to-Free-Cash-Flow 28.05
WOOF's Price-to-Free-Cash-Flow is ranked lower than
56% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 23.72 vs. WOOF: 28.05 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
WOOF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 10.45  Med: 18.53 Max: 37.05
Current: 28.05
10.45
37.05
Price-to-Operating-Cash-Flow 19.21
WOOF's Price-to-Operating-Cash-Flow is ranked lower than
66% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 14.15 vs. WOOF: 19.21 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
WOOF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.26  Med: 12.64 Max: 26.65
Current: 19.21
7.26
26.65
EV-to-EBIT 22.70
WOOF's EV-to-EBIT is ranked lower than
63% of the 292 Companies
in the Global Medical Care industry.

( Industry Median: 18.39 vs. WOOF: 22.70 )
Ranked among companies with meaningful EV-to-EBIT only.
WOOF' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.3  Med: 13.8 Max: 29.5
Current: 22.7
7.3
29.5
EV-to-EBITDA 17.94
WOOF's EV-to-EBITDA is ranked lower than
67% of the 306 Companies
in the Global Medical Care industry.

( Industry Median: 13.46 vs. WOOF: 17.94 )
Ranked among companies with meaningful EV-to-EBITDA only.
WOOF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.5  Med: 11.3 Max: 18.1
Current: 17.94
6.5
18.1
PEG Ratio 1.68
WOOF's PEG Ratio is ranked higher than
72% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 3.11 vs. WOOF: 1.68 )
Ranked among companies with meaningful PEG Ratio only.
WOOF' s PEG Ratio Range Over the Past 10 Years
Min: 0.5  Med: 1.4 Max: 73.79
Current: 1.68
0.5
73.79
Shiller PE Ratio 54.95
WOOF's Shiller PE Ratio is ranked lower than
80% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 28.31 vs. WOOF: 54.95 )
Ranked among companies with meaningful Shiller PE Ratio only.
WOOF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14.95  Med: 29.08 Max: 74.16
Current: 54.95
14.95
74.16
Current Ratio 0.95
WOOF's Current Ratio is ranked lower than
70% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.30 vs. WOOF: 0.95 )
Ranked among companies with meaningful Current Ratio only.
WOOF' s Current Ratio Range Over the Past 10 Years
Min: 0.63  Med: 1.58 Max: 3.69
Current: 0.95
0.63
3.69
Quick Ratio 0.75
WOOF's Quick Ratio is ranked lower than
75% of the 244 Companies
in the Global Medical Care industry.

( Industry Median: 1.18 vs. WOOF: 0.75 )
Ranked among companies with meaningful Quick Ratio only.
WOOF' s Quick Ratio Range Over the Past 10 Years
Min: 0.63  Med: 1.4 Max: 3.62
Current: 0.75
0.63
3.62
Days Inventory 10.87
WOOF's Days Inventory is ranked higher than
65% of the 192 Companies
in the Global Medical Care industry.

( Industry Median: 16.88 vs. WOOF: 10.87 )
Ranked among companies with meaningful Days Inventory only.
WOOF' s Days Inventory Range Over the Past 10 Years
Min: 10.18  Med: 12.37 Max: 14.23
Current: 10.87
10.18
14.23
Days Sales Outstanding 12.41
WOOF's Days Sales Outstanding is ranked higher than
88% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 40.40 vs. WOOF: 12.41 )
Ranked among companies with meaningful Days Sales Outstanding only.
WOOF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 11.51  Med: 12.72 Max: 14.32
Current: 12.41
11.51
14.32
Days Payable 13.01
WOOF's Days Payable is ranked lower than
82% of the 162 Companies
in the Global Medical Care industry.

( Industry Median: 40.41 vs. WOOF: 13.01 )
Ranked among companies with meaningful Days Payable only.
WOOF' s Days Payable Range Over the Past 10 Years
Min: 9.68  Med: 11.29 Max: 13.01
Current: 13.01
9.68
13.01

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio 2.90
WOOF's 3-Year Average Share Buyback Ratio is ranked higher than
93% of the 130 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. WOOF: 2.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
WOOF' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4  Med: 3 Max: 0
Current: 2.9
-4
0

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 2.15
WOOF's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
56% of the 89 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. WOOF: 2.15 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
WOOF' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.84  Med: 1.61 Max: 8.43
Current: 2.15
0.84
8.43
Price-to-Intrinsic-Value-DCF (Earnings Based) 3.34
WOOF's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
91% of the 32 Companies
in the Global Medical Care industry.

( Industry Median: 1.81 vs. WOOF: 3.34 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
N/A
Price-to-Median-PS-Value 1.71
WOOF's Price-to-Median-PS-Value is ranked lower than
83% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. WOOF: 1.71 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
WOOF' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.63  Med: 1.22 Max: 1.88
Current: 1.71
0.63
1.88
Price-to-Peter-Lynch-Fair-Value 1.57
WOOF's Price-to-Peter-Lynch-Fair-Value is ranked higher than
60% of the 47 Companies
in the Global Medical Care industry.

( Industry Median: 2.13 vs. WOOF: 1.57 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
WOOF' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.66  Med: 1.44 Max: 2.09
Current: 1.57
0.66
2.09
Earnings Yield (Greenblatt) % 4.41
WOOF's Earnings Yield (Greenblatt) % is ranked lower than
54% of the 334 Companies
in the Global Medical Care industry.

( Industry Median: 4.98 vs. WOOF: 4.41 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
WOOF' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.4  Med: 7.3 Max: 13.8
Current: 4.41
3.4
13.8
Forward Rate of Return (Yacktman) % 25.16
WOOF's Forward Rate of Return (Yacktman) % is ranked higher than
83% of the 119 Companies
in the Global Medical Care industry.

( Industry Median: 11.19 vs. WOOF: 25.16 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
WOOF' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -3.4  Med: 17.3 Max: 51.2
Current: 25.16
-3.4
51.2

More Statistics

Revenue (TTM) (Mil) $2,517
EPS (TTM) $ 2.56
Beta1.17
Short Percentage of Float1.72%
52-Week Range $59.51 - 91.96
Shares Outstanding (Mil)81.24

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 2,748 3,112
EPS ($) 3.24 3.71
EPS without NRI ($) 3.24 3.71
EPS Growth Rate
(Future 3Y To 5Y Estimate)
9.88%
Dividends per Share ($)
» More Articles for WOOF

Headlines

Articles On GuruFocus.com
Camp Bow Wow Displays One of its Strongest Years of Growth at Close of 2016 and Propels its Successe Mar 31 2017 
Columbia Wanger Buys LCI Industries, Nasdaq Mar 09 2017 
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against VCA Inc. Mar 07 2017 
Stocks Steven Cohen Continues to Buy Mar 02 2017 
Robert Olstein Gains 3 Positions in 4th Quarter Feb 09 2017 
Health Care Companies Showing Good Defensive Potential Dec 22 2016 
WOOF: Health Care Without the Drama Dec 12 2016 
2 Picks in Growing Pet Industry Jan 30 2016 
GuruFocus Real Time Picks of the Week Jun 06 2014 
Morning Coffee: Real-Time Picks May 30 2014 

More From Other Websites
Camp Bow Wow Displays One of its Strongest Years of Growth at Close of 2016 and Propels its... Mar 29 2017
VCA Animal Referral and Emergency Center of Arizona Creates Innovative Prosthetic Device Using 3D... Mar 15 2017
The Zacks Analyst Blog Highlights: Acadia Healthcare, VCA, Universal Health Services and Mednax Mar 09 2017
SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Files Class Action Suit Against VCA Inc. Mar 07 2017
Animal Specialty Center Introduces TrueBeam™ Radiotherapy System for Pet Cancer Treatment Feb 23 2017
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of VCA Inc. - WOOF Feb 16 2017
VCA Animal Hospitals Offers Free Boarding for Pets Affected by Oroville Dam Evacuations in Northern... Feb 13 2017
VCA, Inc. :WOOF-US: Earnings Analysis: 2016 By the Numbers : February 13, 2017 Feb 13 2017
Robert Olstein Gains 3 Positions in 4th Quarter Feb 09 2017
VCA misses Street 4Q forecasts Feb 09 2017
VCA Inc. Reports Fourth Quarter 2016 Results Feb 09 2017
WeissLaw LLP: VCA, Inc. Acquisition May Not Be in the Best Interests of WOOF Shareholders Jan 18 2017
Amazon, Merck, Freshpet: Jim Cramer's Views Jan 16 2017
VCA SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of VCA Inc. (WOOF) Over the... Jan 13 2017
U.S. Pet Care Spending Has Grown 60% Since 2006 (WOOF, IDXX) Jan 13 2017
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of... Jan 12 2017
VCA Looks to Gain Scale and Size by Being Part of Mars Jan 12 2017
VCA INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates... Jan 11 2017
Merck boosts Dow, Amazon prime members get a new perk, ADM to buy pet food producer Jan 11 2017
Robbins Arroyo LLP: Acquisition of VCA Inc. (WOOF) by Mars, Incorporated (Private) May Not Be in... Jan 10 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)